OPTOMED.HEOPTOMED.HEHEL

Revenue (LTM)

$17M

+13.7% YoY

Net Income (LTM)

$-7M

-21.8% YoY

Free Cash Flow

$-3M

Revenue CAGR (5Y)

+5.6%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	15	15↓1.3%	15↑3.0%	15↓0.4%	17↑13.7%
Gross Profit	10	9↓5.5%	10↑11.2%	10↓5.6%	-2↓116.5%
Operating Income	-4	-5↓6.8%	-4↑14.9%	-6↓49.9%	-6↓1.5%
Net Income	-4	-5↓28.8%	-4↑18.8%	-5↓22.7%	-7↓21.8%
EBITDA	-3	-4↓42.4%	-1↑69.2%	-2↓72.1%	-4↓57.5%
EPS Diluted	-0.32	-0.37↓15.6%	-0.27↑27.0%	-0.29↓7.4%	-0.34↓17.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	7	9↑25.3%	7↓16.5%	10↑47.0%	10↓5.3%
Total Current Assets	14	16↑12.0%	13↓18.4%	16↑19.6%	16↑0.4%
Total Assets	29	31↑7.9%	29↓7.1%	32↑9.3%	32↑0.6%
Total Current Liabilities	5	5↑6.4%	5↓3.3%	6↑10.5%	7↑18.1%
Total Liabilities	12	11↓8.3%	9↓20.4%	8↓6.6%	8↓2.3%
Total Equity	17	20↑19.3%	20↑0.1%	24↑16.1%	24↑1.6%
Total Debt	8	7↓18.1%	5↓28.0%	4↓21.6%	4↓6.9%
Net Debt	1	-2↓224.8%	-2↓26.9%	-7↓194.6%	-6↑4.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-3	-2↑19.4%	-1↑74.1%	-2↓159.5%	-2↓55.5%
Capital Expenditure	-3	-3↓17.7%	-2↑20.4%	-2↑12.2%	-1↑73.5%
Free Cash Flow	-6	-5↑2.1%	-3↑43.9%	-4↓22.7%	-3↑18.1%
Stock-Based Comp	0	0↓25.6%	0↓45.8%	0	0
Net Change in Cash	-4	2↑145.2%	-1↓181.7%	3↑338.2%	-1↓116.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance